Blocking a Key Protein Gives Boost to Immune System
Monday, April 15, 2013
UCLA scientists have shown that temporarily blocking a protein critical to immune response actually helps the body clear itself of chronic infection.
MRC Technology and EMBLEM Collaborate to Streamline Drug Development
Monday, April 15, 2013
Initiative strengthens drug development and commercialization network.
Atox Bio Publishes Data Demonstrating the Broad Therapeutic Effect of AB103
Monday, April 15, 2013
Findings published in the Journal of Infectious Diseases.
Ares Life Sciences to Acquire Antigen Laboratories, Inc., in the United States
Monday, April 15, 2013
Ares Life Sciences announced that it has signed a definitive agreement to acquire 100% of the share capital of Planet Biopharmaceuticals, Inc.
Immune Response Linked to Key Enzyme
Friday, April 12, 2013
A family of enzymes may contribute to scientists’ understanding of signaling molecules involved in the body’s immune response.
Early Results of Activartis AV0113 Cancer Immunotherapy in Glioblastoma Trial Reveal Promising Trend
Thursday, April 11, 2013
Glioblastoma multiforme (GBM) is the most severe form of brain cancer and progresses rapidly.
Catalent Biologics Expands into ADCs through Exclusive License with Redwood Bioscience
Thursday, April 11, 2013
SMARTag™ Advanced conjugation technology to be presented at BIO International.
Data Examines Induction of Systemic Immune Response in Multiple Tumor Types
Thursday, April 11, 2013
Provectus Pharmaceuticals, Inc. announced details of a poster presentation on the induction of a systemic immune response with intralesional (IL) PV-10.
Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant
Thursday, April 11, 2013
Inovio to advance painless device to simultaneously deliver multiple vaccines using electroporation technology.
|
|
|
|
|
|
